$0.00
(0.00%)
| Today's Open | $5.01 |
|---|---|
| Previous Close | $5.02 |
| Daily Range | $4.98 - $5.18 |
| 52-Week Range | $2.30 - $6.85 |
| Market Cap | $263.7M |
| P/E Ratio | -5.98 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 318,254 |
| Average Daily Volume | 416,228 |
| Current FY EPS | -$0.83 |
Sector
Healthcare
Industry
Drugs
Sunesis Pharmaceuticals, Inc. (SNSS) Description
The Company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other unmet medical needs. Website: http://www.sunesis.com/
News & Commentary
Data and Safety Monitoring Board Recommends Continuation of Sunesis Pharmaceuticals' VALOR Trial Wit
Data and Safety Monitoring Board Recommends Continuation of Sunesis Pharmaceuticals' VALOR Trial With no Change to Study ConductHere's What This $5 Billion Hedge Fund Has Been Buying
It can pay off to keep an eye on the big guys.Sunesis Pharma Loss Narrows in Q4, Widens in 2012
The drugmaker shaves its quarterly loss, but the annual shortfall deepens.SNSS's Top Competitors
(1.79%)
(2.44%)
(1.78%)
(1.47%)